0% found this document useful (0 votes)
534 views30 pages

Pharmacology For Nurses: A Pathophysiologic Approach: Fifth Edition

Pharmacodynamics

Uploaded by

adni_wg
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
534 views30 pages

Pharmacology For Nurses: A Pathophysiologic Approach: Fifth Edition

Pharmacodynamics

Uploaded by

adni_wg
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 30

Pharmacology for Nurses: A Pathophysiologic

Approach
Fifth Edition

Chapter 5
Pharmacodynamics

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Pharmacodynamics and Interpatient
Variability

• Pharmacodynamics—how a medicine changes the body


• Helps to predict if drug will produce change
• Will ensure that drug will provide safe, effective treatment
• Combination of drug guides and intuitive experience will
guide safe treatment

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Frequency Distribution Curve

• Graphical representation of number of patients


responding to a drug action at different doses
• Peak of curve indicates largest number of patients
responding to drug
• Does not show magnitude of response

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Figure 5.1 Frequency Distribution Curve:
Interpatient Variability in Drug Response

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Median Effective Dose (ED
E D sub 50)
50

• Middle of frequency distribution curve


• Dose that produces therapeutic response in 50% of a
group
• Sometimes called “average” or “standard” dose
• Many patients require more or less

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Nurse’s Skill Critical in Determining if
Average Dose is Effective

• Patient observation
• Taking of vital signs
• Monitoring lab data

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Median Lethal Dose (LD
L D sub 50)
50

• Used to assess safety of a drug


• Shown on frequency distribution curves
• Determined in preclinical trials
• Is lethal dose in 50% of group of animals
• Cannot be experimentally determined in humans

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Median Toxicity Dose (TD 50 )
T D sub50

• Dose that will produce given toxicity in 50% of group of


patients
• Value may be extrapolated from
– Animal data
– Adverse effects in patient clinical trials
• Needed because median lethal dose cannot be tested in
humans

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Therapeutic Index

• Measure of a drug's safety margin


• The higher the value, the safer the drug

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Calculating Therapeutic Index

median lethal dose LD50


Therapeutic index 
median effective dose ED50

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Example of Therapeutic Index

• Therapeutic index of 4: need error four times dose to be


lethal

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Figure 5.2 Therapeutic Index

(a) drug X has a therapeutic index of 4; (b) drug Z has a


therapeutic index of 2. In a human clinical study, LD50
is labeled as TD50 .

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Graded Dose-Response Relationship

• Graphically visualizes differences in responses to


medications in a single patient
• Obtained by observing and measuring patient's
response at different doses of the drug

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Three Phases of Graded Dose–Response
Curve (1 of 2)

• Phase 1: occurs at lowest dose


– Few target cells affected by drug
• Phase 2: straight-line portion of curve
– Most desirable range
– Linear relationship between amount of drug
administered and degree of patient response

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Three Phases of Graded Dose–Response
Curve (2 of 2)

• Phase 3: plateau reached


– Increasing dose has no therapeutic effect
– Increased dose may produce adverse effects

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Figure 5.3 Dose–Response Relationship

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Two Ways to Compare Medications

• Potency
• Efficacy

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Potency

• Drug with higher potency produces a therapeutic effect


at a lower dose, compared with another drug in the
same class

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Efficacy

• Magnitude of maximal response that can be produced


from a particular drug
• From a pharmacotherapeutic perspective, efficacy
almost always more important than potency

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Figure 5.4 Potency and Efficacy

(a) drug A has a higher potency than drug B; (b) drug A


has a higher efficacy than drug B

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Receptor Is Macromolecule

• Molecule to which medication binds in order to initiate its


effects
• Binds endogenous molecules
– Hormones, neurotransmitters, growth factors
• Most drug receptors are protein agonists
• Associated with plasma membrane or intracellular
molecules

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Drug Attaches to Receptor

• Comparable to how thumb drive docks to USB port in a


computer
• May trigger second messenger events
– e.g., activation of specific G proteins and associated
enzymes
• Initiates drug action
• Can stimulate or inhibit normal activity

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Figure 5.5 Cellular Receptors

The red triangle represents the drug binding directly with


receptors.

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Receptor Subtypes Still Being Discovered

• Permit “fine-tuning” of pharmacology


• Two basic receptor types
– Alpha
– Beta
• Drugs affect each subtype differently

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Nonspecific Cellular Responses

• Caused by drugs that act independently of receptors


• Example: changing the permeability of cellular
membranes

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Drugs That Act as Agonists

• Bind to receptor
• Produce same response as endogenous chemical
• Sometimes produce greater maximal response

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Drugs That Act as Partial Agonists

• Bind to receptor
• Produce weaker, less effective response than agonists

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Drugs That Act as Antagonists

• Occupy receptor
• Prevent endogenous chemical from acting
• Often compete with agonists for receptor
• Functional antagonists inhibit the effects of an agonist
not by competing for a receptor, but by changing
pharmacokinetic factors

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
In the Future: Customized Drug Therapy

• End of single-drug, one-size-fits-all policy


• DNA test before receiving drug
• Prevention of idiosyncratic (unpredictable and
unexplained) drug reactions
• Pharmacogenetics—area of pharmacology that
examines role of heredity in drug response

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved
Copyright

Copyright © 2017, 2014, 2011 Pearson Education, Inc. All Rights Reserved

You might also like